Calliditas Therapeutics Presents Data at the 61st European Renal Association Congress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. AAPL
3. JNJ
4. META
5. NRIX
6. SUNS
7. OIG
8. SPY
9. SNDX
10. CRDO

Go back to Calliditas Therapeutics Presents Data at the 61st European Renal Association Congress

Jefferies Downgrades Calliditas Therapeutics (CALT) to Hold

May 28, 2024 1:15 PM EDT

Jefferies analyst Maury Raycroft downgraded Calliditas Therapeutics (NASDAQ: CALT) from Buy to Hold with a price target of $39.00 (from $58.00).

The analyst comments "Asahi Kasei (JPX:3407-T) to acquire CALT for ~$39/ADS (current $38) for ~$1.1B. Transaction was unanimously approved by both cos'... More

Stifel Downgrades Calliditas Therapeutics (CALT) to Hold

May 28, 2024 9:45 AM EDT

Stifel analyst Annabel Samimy downgraded Calliditas Therapeutics (NASDAQ: CALT) from Buy to Hold with a price target of $40.00 (from $55.00).

The analyst comments "Underscoring the increasing activity in nephrology, and specifically IgAN, Asahi Kasei has offered ¥3,076/SEK208/share of CALT or SEK416/ADR... More